Jonathan Mark Hopper - 30 Jun 2021 Form 4 Insider Report for Vericel Corp (VCEL)

Role: Chief Medical Officer
Signature: /s/ Sean Flynn, as Attorney-in-Fact for Jonathan Hopper
Issuer symbol: VCEL
Transactions as of: 30 Jun 2021
Net transactions value: -$57.47
Form type: 4
Filing time: 02 Jul 2021, 16:20:59 UTC
Next filing: 22 Dec 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VCEL	Common Stock	Options Exercise	$7,599	+694	+1.8%	$10.95	39,453	30 Jun 2021	Direct	F1
transaction	VCEL	Common Stock	Sale	$7,657	-134	-0.34%	$57.14	39,319	30 Jun 2021	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VCEL	Stock Option (right to buy)	Options Exercise	$0	-694	-1.2%	$0.000000	57,604	30 Jun 2021	Common Stock	694	$10.95	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
F2	The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2020.
F3	These options, representing the right to purchase 135,000 shares, became exercisable on August 20, 2019, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company.